Cargando…
Diagnostic Accuracy of Adrenal Iodine-131 6-Beta-Iodomethyl-19-Norcholesterol Scintigraphy for the Subtyping of Primary Aldosteronism
Purpose: To evaluate the diagnostic accuracy of the 131I-6β-iodomethyl-19-norcholesterol (NP-59) adrenal scintigraphy for the subtyping diagnosis of primary aldosteronism (PA), considering as gold standard for the diagnosis of unilateral PA (UPA), either the results of the adrenal venous sampling (A...
Autores principales: | Araujo-Castro, Marta, Paja Fano, Miguel, González Boillos, Marga, Pascual-Corrales, Eider, García Cano, Ana María, Parra Ramírez, Paola, Martín Rojas-Marcos, Patricia, Vicente Delgado, Almudena, Casteràs, Anna, Puig, Albert, García Sanz, Iñigo, Díaz Guardiola, Patricia, Robles Lázaro, Cristina, Núñez, Miguel Antonio Sampedro, Guerrero-Vázquez, Raquel, del Castillo Tous, María, Michalopoulou Alevras, Theodora, Tenes Rodrigo, Susana, Hanzu, Felicia A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377416/ https://www.ncbi.nlm.nih.gov/pubmed/37509573 http://dx.doi.org/10.3390/biomedicines11071934 |
Ejemplares similares
-
Ectopic Cortisol-producing Adrenocortical Adenoma Detected by 131I-6β-iodomethyl-norcholesterol Scintigraphy
por: Sato, Seisuke, et al.
Publicado: (2020) -
Imaging of hepatic drug transporters with [(131)I]6-β-iodomethyl-19-norcholesterol
por: Kobayashi, Masato, et al.
Publicado: (2019) -
Author Correction: Imaging of hepatic drug transporters with [(131)I]6-β-iodomethyl-19-norcholesterol
por: Kobayashi, Masato, et al.
Publicado: (2019) -
Diagnostic value of adrenal iodine-131 6-beta-iodomethyl-19-norcholesterol scintigraphy for primary aldosteronism: a retrospective study at a medical center in North Taiwan
por: Wu, Ming-Hsien, et al.
Publicado: (2019) -
Surgical outcomes of patients with primary aldosteronism lateralized with I-131-6 β-iodomethyl-norcholesterol single photon emission/computed tomography without discontinuation or modification of antihypertensive medications
por: Chang, Chia-Hui, et al.
Publicado: (2018)